<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Reuniens Thalamic Nucleus Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Midline Thalamic Nucleus</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Thalamic midline, dorsal thalamus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Projection neurons, interneurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Glutamate (excitatory)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>VGLUT1, Calretinin, Reelin</td>
</tr>
</table>
The Reuniens Thalamic Nucleus (Re) is a prominent midline thalamic nucleus that serves as a critical hub connecting the hippocampus and prefrontal [cortex](/brain-regions/cortex). This bilateral structure plays essential roles in memory consolidation, spatial navigation, and executive function. Recent research has revealed significant involvement of the reuniens nucleus in neurodegenerative diseases, particularly Alzheimer's disease (AD), Parkinson's disease (PD), and related dementias. [@vertes2015]
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Reuniens Thalamic Nucleus Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Midline Thalamic Nucleus</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Thalamic midline, dorsal thalamus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Projection neurons, interneurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Glutamate (excitatory)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>VGLUT1, Calretinin, Reelin</td>
</tr>
</table>
The Reuniens Thalamic Nucleus (Re) is a prominent midline thalamic nucleus that serves as a critical hub connecting the hippocampus and prefrontal [cortex](/brain-regions/cortex). This bilateral structure plays essential roles in memory consolidation, spatial navigation, and executive function. Recent research has revealed significant involvement of the reuniens nucleus in neurodegenerative diseases, particularly Alzheimer's disease (AD), Parkinson's disease (PD), and related dementias. [@vertes2015]
The reuniens nucleus is located in the medial thalamus, straddling the midline. It contains predominantly glutamatergic projection neurons that express vesicular glutamate transporter 1 (VGLUT1), distinguishing it from other thalamic nuclei [1](https://pubmed.ncbi.nlm.nih.gov/25972184/). The nucleus is surrounded by the rhomboid nucleus dorsally and the paratenial nucleus laterally. [@pagano2016]
The reuniens nucleus forms three major pathways:
The reuniens nucleus serves as a critical relay for hippocampal-cortical dialogue during memory consolidation. Single-unit recordings in rodents demonstrate that Re neurons fire phase-locked to hippocampal theta oscillations, facilitating information transfer between the hippocampus and prefrontal cortex during spatial working memory tasks [3](https://pubmed.ncbi.nlm.nih.gov/24684791/).
Prefrontal cortical connections enable the reuniens nucleus to contribute to:
The hippocampus-reuniens-prefrontal circuit integrates spatial information from the hippocampus with contextual information from the prefrontal cortex, enabling complex navigation tasks [4](https://pubmed.ncbi.nlm.nih.gov/26965691/).
As part of the thalamic midline complex, the reuniens contributes to arousal, attention, and conscious perception through widespread cortical projections.
In Alzheimer's disease, the reuniens nucleus undergoes significant neurodegeneration that contributes to the characteristic memory deficits. Postmortem studies reveal:
Transcranial magnetic stimulation (TMS) targeting the medial thalamus, including the reuniens region, has shown promise for improving memory in AD patients [6](https://pubmed.ncbi.nlm.nih.gov/29755290/). Deep brain stimulation (DBS) of thalamic midline structures may restore hippocampal-cortical connectivity.
While primarily considered a motor disorder, Parkinson's disease frequently involves cognitive deficits mediated by prefrontal dysfunction. The reuniens nucleus participates in PD-related cognitive decline through:
Lewy bodies (aggregated alpha-synuclein) have been identified in the reuniens nucleus of PD patients with dementia, suggesting direct involvement in synucleinopathy [7](https://pubmed.ncbi.nlm.nih.gov/30508205/).
FTD involves prominent thalamic degeneration, with the reuniens nucleus showing:
ALS involves thalamic changes beyond motor regions:
Neurodegenerative processes affect excitatory transmission in the reuniens:
Re neurons exhibit calcium-binding protein expression patterns (calretinin, parvalbumin) that may influence disease progression. Calcium dysregulation contributes to:
Microglial activation in the reuniens nucleus has been documented in AD and PD postmortem tissue, suggesting neuroinflammatory contributions to thalamic degeneration.
The reuniens nucleus shows promise as a neuroimaging biomarker:
The study of Reuniens Thalamic Nucleus [Neurons](/entities/neurons) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving Reuniens Thalamic Nucleus Neurons discovered through SciDEX knowledge graph analysis: